GlassScriptPhysician profile
Gregory James Cunn
NPI 1154715183
$56,712.02
in general payments reported to CMS, 2019-2025
36 companies · $10K in 2025
The $10K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $269 · 2021: $17K · 2022: $5,552 · 2023: $13K · 2024: $10K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21K · Travel and Lodging: $11K · Grant: $1,500 · Consulting Fee: $800 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,653.15 |
| Travel and Lodging | $10,504.21 |
| Grant | $1,500.00 |
| Consulting Fee | $800.00 |
| Education | $128.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,792.03 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $17,005.50 | 2021-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Abbott Laboratories | $9,739.97 | 2021-2025 | Aveir, Ensite Precision, Gallant |
| Biosense Webster, INC. | $3,275.69 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Soundstar |
| Biotronik INC. | $1,931.25 | 2021-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Cvrx, INC. | $485.15 | 2021-2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $413.15 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $378.55 | 2019-2024 | Farxiga |
| Angiodynamics, INC. | $329.36 | 2023-2025 | Angiovac, Alphavac |
| Novartis Pharmaceuticals Corporation | $289.21 | 2019-2021 | |
| Horizon Therapeutics Plc | $287.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.91 | 2019-2021 | |
| Atricure, INC. | $239.75 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $234.27 | 2021-2024 | Optimizer |
| Edwards Lifesciences Corporation | $195.72 | 2024 | Hemosphere |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $192.11 | 2020-2021 | |
| Shockwave Medical, INC | $175.40 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $162.65 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| E.R. Squibb & Sons, L.L.C. | $154.75 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $149.59 | 2024 | Impella |
| Janssen Scientific Affairs, LLC | $138.19 | 2024 | |
| Mallinckrodt Hospital Products INC. | $125.00 | 2021 | |
| Genzyme Corporation | $113.99 | 2021 | |
| Elutia, INC. | $113.59 | 2022 | |
| Cordis US Corp. | $71.09 | 2025 | Mynx Control Venous |
| Pfizer INC. | $70.67 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.38 | 2021-2024 | Xarelto |
| Cardiovascular Systems INC. | $62.14 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $52.27 | 2024-2025 | Amvuttra |
| Lilly USA, LLC | $45.75 | 2024-2025 | Zepbound, Mounjaro |
| Volta Medical INC | $34.03 | 2024 | Vx1 |
| Csl Behring | $29.35 | 2024 | Haegarda |
| Nuwellis, INC. | $27.29 | 2019 | |
| Philips North America LLC | $19.32 | 2022 | |
| Heartflow, INC. | $18.50 | 2024 | |
| Itamar Medical INC | $17.25 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.